Abstract:Traditional Chinese medicine(TCM) carries the experience and theoretical knowledge of the ancients, and the use of "toxic" Chinese medicines is a major feature and advantage of TCM. "Toxic" Chinese medicines have unique clinical value and certain medication risk under the guidance of TCM theories such as compatibility for detoxification and treatment based on syndrome differentiation. In recent years, the safety events of Chinese medicines have occurred frequently, which has made the safety of Chinese medicine a public concern in China and abroad. However, limited by conventional cognitive laws and technical methods, basic research on toxicity of Chinese medicines fails to be combined with the clinical application. As a result, it is difficult to identify the clinical characteristics of, predict toxic and side effects of, or form a universal precise medication regimen for "toxic" Chinese medicines, which restricts the clinical application of them. In view of the problem that the toxicity of "toxic" Chinese medicines is difficult to be predicted and restricts the clinical application, the evidence-based research concept will provide new ideas for safe applcation of them in clinical practice. The integrated development of multiple disciplines and techniques in the field of big data and artificial intelligence will also promote the renewal and development of the research models for "toxic" Chinese medicines. Our team tried to propose the academic concept of evidence-based Chinese medicine toxicology and establish the data-intelligence research mode for "toxic" Chinese medicines and the intelligent risk prediction method for medicinal combination in the early stage, which provided methodological supports for solving the above problem. Thus, on the basis of summarizing the research status and problems of the clinical medication regimen of "toxic" Chinese medicines, our team took the evidence-based toxicology of TCM as the core concept, and tried to construct the multiple-evidence integrated evaluation and prediction method for "toxic" Chinese medicine, so as to guide the establishment of the non-toxic medication regimen of "toxic" Chinese medicines. Specifically, through the analysis of multivariate data obtained from the basic research, the evidence-based toxicology database of Chinese medicines and the individualized "toxicity-effect" intelligent prediction platform were built based on the disease-syndrome virtual patients, so as to identify the clinical characteristics and risks of "toxic" Chinese medicines and develop individualized medication regime. This study is expected to provide a methodological reference for the establishment of medication regimen and risk prevention strategy for "toxic" Chinese medicines. The method established in this study will bridge clinical research and basic research, enhance the transformation of the scientific connotation of attenuated compatibility, promote the development of evidence-based Chinese medicine toxicology, and ensure the clinical safety of "toxic" Chinese medicines.

[Pharmacovigilance of Chinese medicine: practice of cognition, application, prevention and rescue of drug toxicity]

Computational Toxicology and Its Application in Toxicity Study of Traditional Chinese Medicine

[Pharmacovigilance of traditional Chinese medicine according to theory of preventive treatment of disease]

Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

Network pharmacology approaches for research of Traditional Chinese Medicines

Safety Research in Traditional Chinese Medicine: Methods, Applications, and Outlook

Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review

[Establishment of multiple evidence-integrated evaluation and prediction method for "toxic" Chinese medicines]

Research progress and frontier of integrated analysis of "toxicity" and "effect" of Traditional Chinese Medicine

[Compatibility for Toxicity Attenuation of Toxic Traditional Chinese Medicine: a Review and Strategies].

Research Progress on Components and Mechanisms of Neurotoxicity Induced by Traditional Chinese Medicine

Bioaccessibility and bioavailability of exogenous and endogenous toxic substances in traditional Chinese medicine and their significance in risk assessment

[Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections]

Enhancing Clinical Efficacy Through the Gut Microbiota: A New Field of Traditional Chinese Medicine

The toxicity and detoxification by processing of traditiona Chinese medicines

A comprehensive review of recent studies on pharmacokinetics of traditional Chinese medicines (2014–2017) and perspectives

'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors

Safety Surveillance of Traditional Chinese Medicine: Current and Future

A Study of Toxicogenomics and Its Current Applications in the Safety of Traditional Chinese Medicine

Thinking on Attact Emphasis to Study of Chinese Formulated Products Contained Strong Toxicity

[Toxicogenomics and its application in safety evaluation of traditional Chinese medicine].